Caco-2 Cell Permeability Assay Protocol for Drug Absorption

Added:

Limitations of Caco-2 Monolayers and the Rise of Multi-Lineage and Microfluidic Models

While the traditional Caco-2 monolayer assay is the historical standard for predicting intestinal drug absorption, it has critical physiological limitations. Derived from colon carcinoma cells, Caco-2 monolayers exhibit tighter junctions than the actual human small intestine, which often leads to the underestimation of paracellular transport. Crucially, they lack a functional mucus layer, express uncharacteristically low levels of key metabolic enzymes (like CYP3A4), and fail to replicate the dynamic mechanical shear stress of peristalsis. To address these shortcomings, researchers are shifting toward more biomimetic alternatives. These include co-culture models (such as Caco-2 with HT29-MTX goblet cells) that introduce a protective mucus barrier, and microfluidic 'Gut-on-a-Chip' systems that incorporate fluid flow and multiple tissue layers. These advanced platforms provide a more physiologically accurate microenvironment, challenging the reliance on traditional static Caco-2 monolayers for predicting human pharmacokinetics.

Basic cell culture techniques and aseptic handling of mammalian cell lines.
Anatomy and physiology of the human intestinal epithelial barrier, including tight junctions and cellular transport pathways (passive diffusion, active transport, and transcytosis).
Fundamentals of pharmacokinetics, specifically the concept of drug absorption and the ADME (Absorption, Distribution, Metabolism, Excretion) framework.
Basic principles of analytical chemistry, particularly how Liquid Chromatography-Mass Spectrometry (LC-MS) is used to identify and quantify compounds in biological samples.
Mathematical calculation of the apparent permeability coefficient (Papp) and efflux ratios to determine active transport vs. passive diffusion.
Application of permeability data in the Biopharmaceutics Classification System (BCS) for predicting drug absorption and seeking regulatory biowaivers.
Advanced intestinal models, such as Caco-2/HT29-MTX co-cultures to simulate the mucus layer, or gut-on-a-chip microfluidic technologies.
Investigating drug-drug interactions (DDIs) mediated by efflux transporters (like P-gp or BCRP) using bidirectional transport assays.
12.8K views100likes4:40@creativebioarray9401Original Release: 2019-07-31

The Caco-2 cell permeability assay uses human colon carcinoma cells cultured on permeable supports to model intestinal epithelium, where differentiated cells form tight junctions and express transporter proteins to predict drug absorption; the method involves cultivating cells for 21 days until polarization is achieved, measuring transepithelial electrical resistance (TEER > 250 Ω·cm²) to confirm monolayer integrity, then performing drug transport experiments with test compounds (10-200 μM) across the monolayer for 1-2 hours, with apparent permeability calculated from collected samples analyzed via LC-MS/MS.